Invention Grant
- Patent Title: Method of preventing of systemic-to-pulmonary-artery shunt thrombosis
-
Application No.: US16609800Application Date: 2018-06-22
-
Publication No.: US11260071B2Publication Date: 2022-03-01
- Inventor: Thomas Diacovo
- Applicant: Chiesi Farmaceutici S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Vorys, Sater, Seymour and Pease LLP
- Agent Maryellen Feehery Hank
- International Application: PCT/EP2018/066817 WO 20180622
- International Announcement: WO2018/234565 WO 20181227
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K31/7076 ; A61P7/02 ; A61K9/00
Abstract:
The present invention is directed to the use of cangrelor for the treatment and/or prevention of shunt thrombosis in patients suffering congenital heart diseases undergoing shunt surgery. The invention is also directed to the use of cangrelor for the treatment and/or prevention of stent thrombosis in pediatric patients undergoing stent implantation.
Public/Granted literature
- US20200054662A1 METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS Public/Granted day:2020-02-20
Information query
IPC分类:
